
The flexible dosing schedule has been approved for patients with skin, lung and cervical cancer

An estimated two million people in the UK are living with undiagnosed chronic obstructive pulmonary disease

The results from a global phase 3 trial show the longest survival data ever reported in this setting

Excessive sweating affects 1-5% of the population and can have a substantial impact on quality of life

A record two million women were prescribed hormone replacement therapy in 2025/26 compared to 0.8 million in 2020/21

Against the backdrop of widespread medicine shortages, Durbin PLC’s rebrand to Uniphar and integration into Uniphar | Global Sourcing represents a strategic move to address industry-wide challenges, expanding its sourcing...

This is the first approved treatment option in the UK for patients with non-segmental vitiligo

US tariffs on UK-produced pharmaceuticals will remain at zero for three years

Today, the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) proudly marks European Laboratory Day, celebrating the professionals at the heart of healthcare decision making. Across Europe, laboratories will...

The treatment is the first and only long-acting HIV prevention option available on the NHS in England and Wales

Lung cancer is the leading cause of cancer-related deaths worldwide

The Commission will unite healthcare leaders, regulators and technology experts to shape future AI governance